M Ceroni

Summary

Affiliation: University of Pavia
Country: Italy

Publications

  1. ncbi request reprint Amyotrophic lateral sclerosis and SOD1 gene: an overview
    M Ceroni
    IRCCS C Mondino Institute of Neurology, Laboratory of Experimental Neurobiology, Maugeri Mondino University of Pavia Research Center, Italy
    Funct Neurol 16:171-80. 2001
  2. ncbi request reprint Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation
    M Ceroni
    Department of Neuroscience, Istituto Neurologico C Mondino, Pavia, Italy
    Neurology 53:1064-71. 1999
  3. ncbi request reprint Migraine with aura and white matter abnormalities: Notch3 mutation
    M Ceroni
    Istituto Neurologico IRCCS C Mondino, Pavia, Italy
    Neurology 54:1869-71. 2000
  4. ncbi request reprint SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation
    D Curti
    Department of Cellular and Molecular Physiological and Pharmacological Sciences, Neurological Institute C Mondino, University of Pavia, Pavia, Italy
    Amyotroph Lateral Scler Other Motor Neuron Disord 3:115-22. 2002
  5. doi request reprint Effect of the 50 bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients
    P Milani
    Laboratory of Experimental Neurobiology, IRCCS, National Neurological Institute C Mondino, Via Mondino 2, 27100 Pavia, Italy
    J Neurol Sci 313:75-8. 2012
  6. ncbi request reprint Immunohistochemical evaluation of minichromosome maintenance protein 7 in astrocytoma grading
    A Facoetti
    Dipartimento di Biologia Animale, Universita di Pavia, Pavia, Italy
    Anticancer Res 26:3513-6. 2006
  7. ncbi request reprint Minichromosome maintenance protein 7: a reliable tool for glioblastoma proliferation index
    A Facoetti
    Dipartimento di Biologia Animale, Universita di Pavia, Pavia, Italy
    Anticancer Res 26:1071-5. 2006
  8. ncbi request reprint Activated lymphoid cells in human gliomas: morphofunctional and cytochemical evidence
    R Nano
    Department of Animal Biology, University of Pavia, Italy
    Anticancer Res 17:107-11. 1997
  9. ncbi request reprint Dejerine's syndrome or Spiller's syndrome?
    P Pergami
    Neurological Institute ISCCS C Mondino, Pavia, Italy
    Neurol Sci 22:333-6. 2001
  10. ncbi request reprint Effect of nitric oxide on lymphocytes from sporadic amyotrophic lateral sclerosis patients: toxic or protective role?
    C Cereda
    Laboratory of Experimental Neurobiology, I R C C S Foundation C Mondino Institute of Neurology, Centro Ricerche, Via Mondino 1, I 27100 Pavia, Italy
    Neurol Sci 27:312-6. 2006

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Amyotrophic lateral sclerosis and SOD1 gene: an overview
    M Ceroni
    IRCCS C Mondino Institute of Neurology, Laboratory of Experimental Neurobiology, Maugeri Mondino University of Pavia Research Center, Italy
    Funct Neurol 16:171-80. 2001
  2. ncbi request reprint Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation
    M Ceroni
    Department of Neuroscience, Istituto Neurologico C Mondino, Pavia, Italy
    Neurology 53:1064-71. 1999
    ..To study three new apparently unrelated Italian families with ALS and several sporadic ALS patients living in the same rural area...
  3. ncbi request reprint Migraine with aura and white matter abnormalities: Notch3 mutation
    M Ceroni
    Istituto Neurologico IRCCS C Mondino, Pavia, Italy
    Neurology 54:1869-71. 2000
    ..White matter abnormalities occur in a variable percentage of the general migraine population; CADASIL should be suspected in migraineurs with prolonged atypical aura and white matter abnormalities...
  4. ncbi request reprint SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation
    D Curti
    Department of Cellular and Molecular Physiological and Pharmacological Sciences, Neurological Institute C Mondino, University of Pavia, Pavia, Italy
    Amyotroph Lateral Scler Other Motor Neuron Disord 3:115-22. 2002
    ..Three of the fALS patients and the L84F(5) subject were tested once a year for three consecutive years...
  5. doi request reprint Effect of the 50 bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients
    P Milani
    Laboratory of Experimental Neurobiology, IRCCS, National Neurological Institute C Mondino, Via Mondino 2, 27100 Pavia, Italy
    J Neurol Sci 313:75-8. 2012
    ..30). Our data suggest that the studied polymorphism does not modulate SOD1 mRNA level and disease phenotype in an Italian population...
  6. ncbi request reprint Immunohistochemical evaluation of minichromosome maintenance protein 7 in astrocytoma grading
    A Facoetti
    Dipartimento di Biologia Animale, Universita di Pavia, Pavia, Italy
    Anticancer Res 26:3513-6. 2006
    ..MCM7 significantly stained more nuclei compared to Ki67 in all the histopathological grades investigated. In addition, a stronger increase of the MCM7 labelling index, in relation to the tumor aggressiveness, was observed...
  7. ncbi request reprint Minichromosome maintenance protein 7: a reliable tool for glioblastoma proliferation index
    A Facoetti
    Dipartimento di Biologia Animale, Universita di Pavia, Pavia, Italy
    Anticancer Res 26:1071-5. 2006
    ..These results suggest that the cell cycle-associated proteins MCM are not only useful markers of proliferation, but also valid aids for diagnosis in cerebral glioblastoma...
  8. ncbi request reprint Activated lymphoid cells in human gliomas: morphofunctional and cytochemical evidence
    R Nano
    Department of Animal Biology, University of Pavia, Italy
    Anticancer Res 17:107-11. 1997
    ..These findings indicate that in malignant gliomas there is stimulation of the immune system as witnessed by the presence of activated cells inside tumor tissue and soluble activating factors in serum...
  9. ncbi request reprint Dejerine's syndrome or Spiller's syndrome?
    P Pergami
    Neurological Institute ISCCS C Mondino, Pavia, Italy
    Neurol Sci 22:333-6. 2001
    ....
  10. ncbi request reprint Effect of nitric oxide on lymphocytes from sporadic amyotrophic lateral sclerosis patients: toxic or protective role?
    C Cereda
    Laboratory of Experimental Neurobiology, I R C C S Foundation C Mondino Institute of Neurology, Centro Ricerche, Via Mondino 1, I 27100 Pavia, Italy
    Neurol Sci 27:312-6. 2006
    ..Surprisingly, in SALS lymphocytes the NONO treatment increased the expression of these proteins, which in basal conditions was depressed compared to control lymphocytes...
  11. doi request reprint NMO-IgG-negative relapsing myelitis
    S Ravaglia
    Institute of Neurology C Mondino, University of Pavia, Pavia, Italy
    Spinal Cord 47:531-7. 2009
    ..Our objective was to evaluate the frequency of recurrent I-TM; to clarify the nosology of these forms through comparison with NMO and post-infectious TM (P-TM)...
  12. ncbi request reprint Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis
    E Marchioni
    Neurological Institute IRCCS C Mondino, Pavia, Italy
    J Neurol 249:100-4. 2002
    ..One patient experienced a good effect nothwithstanding a steady dysability. In all cases, clinical evidence was supported by MRI controls showing improving posttreatment changes...
  13. ncbi request reprint A randomized phase III study: comparison between intravenous and intraarterial ACNU administration in newly diagnosed primary glioblastomas
    F Imbesi
    Department of Neurology, Policlinico di Monza, Italy
    Anticancer Res 26:553-8. 2006
    ..In this randomized phase III study, the effectiveness as well as the side-effects of intraarterial [i.a.] (17 patients) versus intravenous [i.v.] (16 patients) ACNU [Nimustine] administration in newly diagnosed glioblastoma, were compared...
  14. doi request reprint Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis
    Ettore Beghi
    Clinica Neurologica, Universita di Milano Bicocca, Monza
    Amyotroph Lateral Scler 9:163-7. 2008
    ..In conclusion, patients with ALS differ in terms of measures and predictors of disability. These factors are sources of bias and confounding in randomized clinical trials...